Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Uterine Cervical Neoplasms × Neoadjuvant Therapy × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 8 Neoplasms 3 Triple Negative Breast Neoplasms 2 Rectal Neoplasms 2 Lung Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 1 Squamous Cell Carcinoma of External Auditory Canal 1 Sarcoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Ovarian Neoplasms 1 Neoplasm, Residual 1 Multiple Myeloma 1 Microsatellite Instability 1 Melanoma 1 Medulloblastoma 1 Liposarcoma 1 Leiomyosarcoma 1 Intermittent Fasting 1 High-Risk Cancer 1 Head and Neck Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1 Carcinoma, Hepatocellular 1 Breast Neoplasms, Male 1

Interventions

pembrolizumab 19 Cisplatin 9 Carboplatin 8 Bevacizumab 8 Specimen Handling 7 Radiotherapy 7 Human Papillomavirus DNA Tests 7 Colposcopy 7 Paclitaxel 6 Magnetic Resonance Spectroscopy 5 Gemcitabine 5 Biopsy 5 lenvatinib 4 Fulvestrant 4 Drug Therapy 4 zimberelimab 3 toripalimab 3 tisotumab vedotin 3 dostarlimab 3 atezolizumab 3 Topotecan 3 Restraint, Physical 3 Radiotherapy, Intensity-Modulated 3 Pemetrexed 3 Nivolumab 3 Mass Screening 3 Cyclophosphamide 3 Brachytherapy 3 spartalizumab 2 fludarabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡